TP-03, a topical ophthalmic preparation of an established acaricide, significantly reduced Demodex density and cylindrical dandruff through 90 days of treatment in a phase 2a pilot study.
“TP-03 is a novel topical ophthalmic drug with uniquely designed properties to most effectively and safely target the mite’s nervous system and paralyze and kill mites. It is currently being developed in a multidose preserved formulation,” Roberto Gonzalez-Salinas, MD, PhD, said at the virtual Association for Research in Vision and Ophthalmology meeting.
Gonzalez-Salinas and colleagues
Uncategorized